Qiagen Stock - Friday review and sector comparison
19.06.2026 - 21:16:49 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:16 CET. Details in the imprint.
Qiagen (NL0012169213) enters this Friday session without any new price-moving corporate announcements or regulatory filings. The stock instead reflects sector sentiment in diagnostics and life-science tools, as recent market data and peer performance indicate.
Background and price data on Qiagen stock
All current news, market data and corporate disclosures on Qiagen stock can be found bundled on the ad hoc news topic page and in the company's own investor relations area.
What Reuters and peers show
There is no fresh Qiagen-specific filing or press release on 06/19/2026 from the company's investor relations page or the major wires. Recent coverage instead frames the stock within a calm diagnostics sector environment, with no idiosyncratic catalyst flagged by leading news services.
Qiagen stock is quoted on the New York Stock Exchange under the ticker QGEN and last closed at $37.00 on 06/18/2026, according to consolidated quote data referenced by MarketBeat. Extended trading after the close showed only a marginal move, underscoring the muted near-term news flow.
Friday review and sector comparison
With no new company news, investors this Friday mainly check how Qiagen compares with other life-science tools and diagnostics names over the week. Recent trading patterns show that several large-cap peers also moved within relatively narrow ranges, suggesting a sector driven more by macro sentiment than by single-stock headlines.
Against this backdrop, Qiagen's valuation and earnings profile stand next to diversified groups such as Thermo Fisher Scientific and Danaher, which likewise balance recurring consumables revenues with more cyclical instrument demand. The sector as a whole benefits from structural drivers like aging populations and rising molecular testing volumes, even when individual news flow is quiet.
The product behind the stock
Qiagen generates most of its revenue from sample preparation kits, assays and instruments for molecular diagnostics and research, including its widely used QIAamp DNA Mini Kit for DNA purification and the QIAcube platform for automated sample processing. These tools underpin routine laboratory workflows worldwide.
Where the stock trades today
The shares of Qiagen (NL0012169213) trade on the New York Stock Exchange at $37.00 as of 06/18/2026, 15:59 ET.
Key facts on Qiagen stock
- Company: QIAGEN N.V.
- ISIN: NL0012169213
- WKN: A2DKCH
- Ticker: QGEN
- Venue: NYSE
- Price (as of 06/18/2026, 15:59 ET): 37.00 USD
- Market cap: 8,57 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: Not a member of the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
